SV2002000776A - Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv - Google Patents

Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv

Info

Publication number
SV2002000776A
SV2002000776A SV2001000776A SV2001000776A SV2002000776A SV 2002000776 A SV2002000776 A SV 2002000776A SV 2001000776 A SV2001000776 A SV 2001000776A SV 2001000776 A SV2001000776 A SV 2001000776A SV 2002000776 A SV2002000776 A SV 2002000776A
Authority
SV
El Salvador
Prior art keywords
lea
ref
new substituted
substituted imidazotriazinones
imidazotriazinones
Prior art date
Application number
SV2001000776A
Other languages
English (en)
Inventor
Ulrich Niewohner
Dagmer Schauss
Martin Hendrix
Gerhard Konig
Frank Gerhard Boss
Der Staay Franz Josef Van
Rudy Schreiber
Karl-Heinz Schlemmer
Rolf Grosser
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV2002000776A publication Critical patent/SV2002000776A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVAS IMIDAZOTRIAZINONAS SUSTITUIDAS, A PROCEDIMIENTOS PARA SU PREPARACION Y A SU USO PARA LA PREPARACION DE MEDICAMENTOS, ESPECIALMENTE PARA LA MEJORA E LA PERCEPCION, LA CAPACIDAD DE CONCENTRACION, LA CAPACIDAD DE APRENDIZAJE Y/O LA CAPACIDAD DE MEMORIA.
SV2001000776A 2000-12-21 2001-12-20 Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv SV2002000776A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10064105A DE10064105A1 (de) 2000-12-21 2000-12-21 Neue Substituierte Imidazotriazinone

Publications (1)

Publication Number Publication Date
SV2002000776A true SV2002000776A (es) 2002-12-02

Family

ID=7668333

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000776A SV2002000776A (es) 2000-12-21 2001-12-20 Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv

Country Status (15)

Country Link
US (1) US6573263B2 (es)
EP (1) EP1347978B1 (es)
JP (1) JP2004525098A (es)
AR (1) AR034423A1 (es)
AU (1) AU2002216087A1 (es)
CA (1) CA2431965A1 (es)
DE (2) DE10064105A1 (es)
DO (1) DOP2001000297A (es)
ES (1) ES2248228T3 (es)
GT (1) GT200100254A (es)
HN (1) HN2001000281A (es)
PE (1) PE20020756A1 (es)
SV (1) SV2002000776A (es)
UY (1) UY27080A1 (es)
WO (1) WO2002050078A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113342D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 1
US7087605B2 (en) 2001-06-01 2006-08-08 Bayer Aktiengesellschaft 5-Ethyl-imidazotriazinones
PL372295A1 (en) * 2002-02-04 2005-07-11 F.Hoffmann-La Roche Ag Quinoline derivatives as npy antagonists
CA2489251A1 (en) * 2002-07-05 2004-01-15 F. Hoffmann-La Roche Ag Quinazoline derivatives
AU2003253364B2 (en) * 2002-08-07 2007-06-07 F. Hoffmann-La Roche Ag Thiazole derivatives
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体
EA029892B1 (ru) 2012-04-25 2018-05-31 Такеда Фармасьютикал Компани Лимитед Азотсодержащее гетероциклическое соединение
JP6205356B2 (ja) * 2012-07-13 2017-09-27 武田薬品工業株式会社 複素環化合物
EP2975031A4 (en) 2013-03-14 2017-04-19 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP6411342B2 (ja) 2013-07-03 2018-10-24 武田薬品工業株式会社 アミド化合物
EP3018126A4 (en) 2013-07-03 2016-12-07 Takeda Pharmaceuticals Co HETEROCYCLIC CONNECTION
WO2015096651A1 (en) 2013-12-23 2015-07-02 Merck Sharp & Dohme Corp. Pyrimidone carboxamide compounds as pde2 inhibitors
JP6696904B2 (ja) * 2014-01-08 2020-05-20 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 製剤および医薬組成物
EP3134413B1 (en) 2014-04-23 2019-09-11 Dart NeuroScience (Cayman) Ltd. Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors
TWI568737B (zh) 2014-11-05 2017-02-01 達特神經科學（開曼）有限責任公司 作為ｐｄｅ２抑制劑之經取代的５－甲基－［１，２，４］三唑并［１，５－ａ］嘧啶－２－胺化合物
BR112017012007B1 (pt) 2014-12-06 2022-11-01 Intra-Cellular Therapies, Inc Compostos orgânicos inibitórios de pde2, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento de um distúrbio mediado por pde2
WO2016090382A1 (en) 2014-12-06 2016-06-09 Intra-Cellular Therapies, Inc. Organic compounds
WO2016145614A1 (en) 2015-03-17 2016-09-22 Merck Sharp & Dohme Corp. Triazolyl pyrimidinone compounds as pde2 inhibitors
EP3285581B1 (en) 2015-03-26 2021-08-11 Merck Sharp & Dohme Corp. Pyrazolyl pyrimidinone compounds as pde2 inhibitors
EP3291817B1 (en) 2015-05-05 2019-10-02 Merck Sharp & Dohme Corp. Heteroaryl-pyrimidinone compounds as pde2 inhibitors
WO2016183741A1 (en) 2015-05-15 2016-11-24 Merck Sharp & Dohme Corp. Pyrimidinone amide compounds as pde2 inhibitors
WO2016191935A1 (en) 2015-05-29 2016-12-08 Merck Sharp & Dohme Corp. 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors
WO2016192083A1 (en) 2015-06-04 2016-12-08 Merck Sharp & Dohme Corp. Dihydropyrazolopyrimidinone compounds as pde2 inhibitors
US10647727B2 (en) 2015-06-25 2020-05-12 Merck Sharp & Dohme Corp. Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors
WO2017000277A1 (en) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Substituted triazolo bicycliccompounds as pde2 inhibitors
WO2017000276A1 (en) 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
US11419874B2 (en) 2017-11-23 2022-08-23 Oslo University Hospital Hf Treatment of tachycardia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK109578A (da) 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
DE19541264A1 (de) 1995-11-06 1997-05-07 Bayer Ag Purin-6-on-derivate
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
HU227841B1 (en) * 1997-11-12 2012-05-02 Bayer Pharma AG 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
DE19838705A1 (de) 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one

Also Published As

Publication number Publication date
DOP2001000297A (es) 2003-08-15
UY27080A1 (es) 2002-07-31
HN2001000281A (es) 2003-02-04
ES2248228T3 (es) 2006-03-16
WO2002050078A1 (de) 2002-06-27
EP1347978A1 (de) 2003-10-01
DE50107316D1 (de) 2005-10-06
US6573263B2 (en) 2003-06-03
CA2431965A1 (en) 2002-06-27
EP1347978B1 (de) 2005-08-31
US20020198377A1 (en) 2002-12-26
PE20020756A1 (es) 2002-10-02
AR034423A1 (es) 2004-02-25
GT200100254A (es) 2002-08-19
JP2004525098A (ja) 2004-08-19
AU2002216087A1 (en) 2002-07-01
DE10064105A1 (de) 2002-06-27

Similar Documents

Publication Publication Date Title
DOP2001000297A (es) Nuevas imidazotriazinonas sustituidas
SV2003001107A (es) Imidazotriazinas ref.lea 35368
SV2004001432A (es) 2-tio-3,5-diciano-4-4fenil-6-aminopiridinas substituidas y su uso ref. lea 35 640-sv
ATE231872T1 (de) Thiazolopyrimidinderivate
SV2003001172A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso ref. lea 35510-sv
SE0301653D0 (sv) Novel compounds
SV1997000003A (es) Tienil- y furanil-oxazolidinonas piridocondensadas ref. lea 31502-sv
HN2002000300A (es) Nuevos derivados de piperazina
AR030185A1 (es) Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas
UY28312A1 (es) Pirazolopirimidinas sustituidas con 6-ciclimetilo y 6-alquilmetilo
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
BR9713499A (pt) Halogenopirimidinas
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
HN2001000235A (es) Derivados puentes de piperazina
HN2002000278A (es) Tetrahidroquinolinas
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR0308201A (pt) Derivados de quinolina
SV2002000355A (es) Aril- y heteroarilsulfonatos ref. lea 34321-sv
SV2003001061A (es) Nuevos heterociclos 3 ref.lea 35361-sv
SE0102910D0 (sv) New use
SV2004001441A (es) Compuestos de isocromano ref. x-14205
SV2002000639A (es) Alcanosulfonatos de fenoxifenilo ref. lea 34813-sv
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.
BR9810407A (pt) Compostos fluormetoximino
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner